Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001746473-25-000132
Filing Date
2025-06-09
Accepted
2025-06-09 20:44:53
Documents
2
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749516282.html 4  
1 FORM 4 wk-form4_1749516282.xml 4 4210
2 EX-24 poa_bruhn.txt EX-24 4339
  Complete submission text file 0001746473-25-000132.txt   10031
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN TX 78746
Business Address
Bruhn Suzanne Louise (Reporting) CIK: 0001517790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 251035737

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)